These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 16406167

  • 1. Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes.
    Görzer I, Niesters HG, Cornelissen JJ, Puchhammer-Stöckl E.
    Virus Res; 2006 Jun; 118(1-2):105-14. PubMed ID: 16406167
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus latent gene sequences as geographical markers of viral origin: unique EBNA3 gene signatures identify Japanese viruses as distinct members of the Asian virus family.
    Sawada A, Croom-Carter D, Kondo O, Yasui M, Koyama-Sato M, Inoue M, Kawa K, Rickinson AB, Tierney RJ.
    J Gen Virol; 2011 May; 92(Pt 5):1032-1043. PubMed ID: 21248177
    [Abstract] [Full Text] [Related]

  • 3. Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene.
    Correa RM, Fellner MD, Alonio LV, Durand K, Teyssié AR, Picconi MA.
    J Med Virol; 2004 Aug; 73(4):583-8. PubMed ID: 15221903
    [Abstract] [Full Text] [Related]

  • 4. Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity.
    Saechan V, Mori A, Mitarnun W, Settheetham-Ishida W, Ishida T.
    J Clin Virol; 2006 Jun; 36(2):119-25. PubMed ID: 16616610
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma.
    Chen YY, Chang KL, Chen WG, Shibata D, Hayashi K, Weiss LM.
    Lab Invest; 1998 Jul; 78(7):877-82. PubMed ID: 9690565
    [Abstract] [Full Text] [Related]

  • 6. Widespread sequence variation in the Epstein-Barr virus latent membrane protein 2A gene among northern Chinese isolates.
    Wang X, Liu X, Jia Y, Chao Y, Xing X, Wang Y, Luo B.
    J Gen Virol; 2010 Oct; 91(Pt 10):2564-73. PubMed ID: 20554797
    [Abstract] [Full Text] [Related]

  • 7. Detection of a nuclear antigen 2 (EBNA2)-variant Epstein-Barr virus strain in two siblings with fatal lymphoproliferative disease.
    Schuster V, Seidenspinner S, Kreth HW.
    J Med Virol; 1996 Jan; 48(1):114-20. PubMed ID: 8825720
    [Abstract] [Full Text] [Related]

  • 8. Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection.
    Palser AL, Grayson NE, White RE, Corton C, Correia S, Ba Abdullah MM, Watson SJ, Cotten M, Arrand JR, Murray PG, Allday MJ, Rickinson AB, Young LS, Farrell PJ, Kellam P.
    J Virol; 2015 May; 89(10):5222-37. PubMed ID: 25787276
    [Abstract] [Full Text] [Related]

  • 9. Characterization of intertypic recombinants of the Epstein-Barr virus from the body-cavity-based lymphomas cell lines BC-1 and BC-2.
    Aguirre AJ, Robertson ES.
    Virology; 1999 Nov 25; 264(2):359-69. PubMed ID: 10562498
    [Abstract] [Full Text] [Related]

  • 10. The molecular epidemiology and evolution of Epstein-Barr virus: sequence variation and genetic recombination in the latent membrane protein-1 gene.
    Walling DM, Shebib N, Weaver SC, Nichols CM, Flaitz CM, Webster-Cyriaque J.
    J Infect Dis; 1999 Apr 25; 179(4):763-74. PubMed ID: 10068570
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
    Wang A, Welch R, Zhao B, Ta T, Keleş S, Johannsen E.
    J Virol; 2015 Dec 30; 90(6):2906-19. PubMed ID: 26719268
    [Abstract] [Full Text] [Related]

  • 12. Antisense to Epstein Barr Virus-encoded LMP1 does not affect the transcription of viral and cellular proliferation-related genes, but induces phenotypic effects on EBV-transformed B lymphocytes.
    Masciarelli S, Mattioli B, Galletti R, Samoggia P, Chichiarelli S, Mearini G, Mattia E.
    Oncogene; 2002 Jun 13; 21(26):4166-70. PubMed ID: 12037673
    [Abstract] [Full Text] [Related]

  • 13. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas.
    Guiretti DM, Chabay PA, Valva P, Stefanoff CG, Barros MH, De Matteo E, Renault IZ, Preciado MV, Hassan R.
    J Med Virol; 2007 Nov 13; 79(11):1730-22. PubMed ID: 17854036
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus infection is not associated with fibroadenomas of the breast in immunosuppressed patients after organ transplantation.
    Lau SK, Chen YY, Berry GJ, Yousem SA, Weiss LM.
    Mod Pathol; 2003 Dec 13; 16(12):1242-7. PubMed ID: 14681325
    [Abstract] [Full Text] [Related]

  • 15. Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection.
    Shibata Y, Hoshino Y, Hara S, Yagasaki H, Kojima S, Nishiyama Y, Morishima T, Kimura H.
    J Med Virol; 2006 Jun 13; 78(6):770-9. PubMed ID: 16628581
    [Abstract] [Full Text] [Related]

  • 16. Are particular Epstein-Barr virus strains linked to disease?
    Jenkins PJ, Farrell PJ.
    Semin Cancer Biol; 1996 Aug 13; 7(4):209-15. PubMed ID: 8946605
    [Abstract] [Full Text] [Related]

  • 17. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
    Tiwawech D, Srivatanakul P, Karalak A, Ishida T.
    J Clin Virol; 2008 May 13; 42(1):1-6. PubMed ID: 18180201
    [Abstract] [Full Text] [Related]

  • 18. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.
    Jiang H, Cho YG, Wang F.
    J Virol; 2000 Jul 13; 74(13):5921-32. PubMed ID: 10846073
    [Abstract] [Full Text] [Related]

  • 19. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter.
    Le Roux A, Kerdiles B, Walls D, Dedieu JF, Perricaudet M.
    Virology; 1994 Dec 13; 205(2):596-602. PubMed ID: 7975264
    [Abstract] [Full Text] [Related]

  • 20. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ, Smits PH, Verkuijlen SA, Rockx DA, van Gorp EC, Mulder JW, Middeldorp JM.
    AIDS; 2007 Oct 18; 21(16):2141-9. PubMed ID: 18090040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.